Anderson-Dring, Lauren
AstraZeneca (United Kingdom)
3 papers on CoChat
Most cited papers
- Verified
Rare variant associations with plasma protein levels in the UK Biobank
Dhindsa, R. S., Burren, O. S., Sun, B. B., Prins, B. P., Matelska, D., Wheeler, E., Mitchell, J., Oerton, E., Hristova, V. A., Smith, K. R., et al. (2023) · Nature
Genetic Associations and EpidemiologyGenomics and Rare Diseases
Cited by 193
- Verified
In Vitro and In Vivo Antifungal Profile of a Novel and Long-Acting Inhaled Azole, PC945, on Aspergillus fumigatus Infection
Colley, T., Alanio, A., Kelly, S. L., Sehra, G., Kizawa, Y., Warrilow, A. G. S., Parker, J. E., Kelly, D. E., Kimura, G., Anderson-Dring, L., et al. (2017) · Antimicrobial Agents and Chemotherapy
Antifungal resistance and susceptibilityFungal Plant Pathogen Control
Cited by 87
- Verified
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases
Mitchell, J., Camacho, N., Shea, P., Stopsack, K. H., Joseph, V., Burren, O. S., Dhindsa, R. S., Nag, A., Berchuck, J. E., O’Neill, A., et al. (2025) · Nature Communications
BRCA gene mutations in cancerProstate Cancer Treatment and Research
Cited by 19
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free